Progyny, Inc.

PGNY

Progyny, Inc.

PGNY

Insider Sentiment (TTM):

Last Purchase:2025-11-13Last Sale:2026-06-04Shares Purchased (TTM):79,500Shares Sold (TTM):73,771

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:68,102,599Shares Outstanding:80,920,993Institutional Ownership Pct.:84.16%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Services-Misc Health & Allied Services, NEC

DVA SHC VMD AGL PARK CCEL

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	132	112	134	133	109	162	91	95	115	97	158	171
Available For Sale Securities Debt Securities Curr…	94	198	211	173	147	66	144	167	257	274	177	112
Accounts Receivable Net Current	264	220	253	272	300	235	281	294	297	242	269	265
Prepaid Expense And Other Assets Current	13	21	24	17	12	9	30	26	12	27	7	14
Assets Current	502	552	622	594	568	473	546	582	682	640	611	561
Property Plant And Equipment Net	36	30	25	20	16	12	12	11	10	10	10	9
Operating Lease Right Of Use Asset	24	25	26	26	27	17	17	18	17	18	18	18
Goodwill	20	20	20	20	20	16	16	16	12	12	12	12
Finite Lived Intangible Assets Net	6	6	6	7	7	1	1	1	-	0	0	0
Deferred Income Tax Assets Net	93	93	85	85	85	85	64	68	70	73	72	77
Other Assets Noncurrent	18	17	12	9	9	3	3	3	3	3	4	4
Assets	698	742	795	761	730	607	660	699	794	757	727	682
Liabilities And Stockhold…
Liabilities Current
Liabilities
Accounts Payable Current	158	124	123	141	146	95	130	152	130	125	132	130
Liabilities Current	236	202	210	220	237	169	208	225	206	186	193	194
Operating Lease Liability Noncurrent	23	24	25	26	26	16	17	17	17	17	18	18
Liabilities	259	226	235	246	263	185	225	242	223	203	211	212
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	718	701	673	642	612	582	552	520	489	462	438	409
Treasury Stock Common Value	-506	-388	-304	-304	-304	-304	-251	-189	-27	-1	-1	-1
Retained Earnings Accumulated Deficit	227	203	190	176	159	144	134	123	107	90	77	61
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	2	3	3	2	1
Stockholders Equity	439	516	560	515	467	422	435	456	572	553	515	469
Liabilities And Stockholders Equity	698	742	795	761	730	607	660	699	794	757	727	682
Accounts Receivable Net C…
Allowance For Doubtful Accounts Receivable	56	56	55	-	-	56	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Allowance For Doubtful Accounts Receivable Current	-	-	-	-	-	56	56	54	50	47	43	38
Common Stock Number Of Sh…
Common Stock Shares Issued	99	99	99	98	98	98	97	97	97	96	96	95
Shares Outstanding	78	83	86	86	86	85	88	91	96	96	96	95
Treasury Stock Number Of …
Treasury Stock Common Shares	22	16	13	13	13	13	10	7	1	1	1	1

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.76%	20.19%	-	-	-	-	-	-	-	-	-	-
2025	1.46%	3.40%	9.06%	3.59%	-6.08%	-14.70%	17.88%	15.33%	12.74%	2.49%	2.43%	31.43%
2024	-2.11%	3.92%	5.85%	12.66%	-19.42%	-25.90%	-14.09%	2.44%	34.87%	-0.45%	3.45%	-6.73%
2023	3.23%	4.07%	7.43%	-12.87%	-22.87%	-26.18%	17.21%	25.99%	27.72%	1.97%	-10.46%	-23.08%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.13	2.73	2.96	2.70	2.39	2.80	2.62	2.58	3.31	3.44	3.16	2.89
Quick Ratio	2.07	2.62	2.84	2.62	2.34	2.75	2.48	2.47	3.25	3.30	3.12	2.82
Working Capital	265.81M	349.38M	411.52M	373.98M	330.56M	304.09M	337.83M	356.87M	475.59M	454.46M	417.85M	367.23M
Leverage & Debt
Debt to Equity	0.59	0.44	0.42	0.48	0.56	0.44	0.52	0.53	0.39	0.37	0.41	0.45
Interest Coverage TTM	-	-	-	-	89.59	46.58	29.89	22.08	21.10	18.82	16.56	19.54
Debt Ratio	0.37	0.30	0.30	0.32	0.36	0.30	0.34	0.35	0.28	0.27	0.29	0.31
Efficiency & Turnover
Asset Turnover TTM	1.81	1.91	1.74	1.70	1.59	1.71	2.82	2.83	2.67	2.94	2.60	2.67
Days Sales Outstanding TTM	79.51	64.52	76.70	83.12	89.80	74.61	51.23	52.25	57.82	46.12	59.88	59.02
Receivables Turnover TTM	4.59	5.66	4.76	4.39	4.06	4.89	7.12	6.99	6.31	7.91	6.10	6.18
Per Share Metrics
Diluted EPS TTM	0.80	0.65	0.63	0.59	0.59	0.57	0.61	0.64	0.61	0.62	0.52	0.49
Free Cash Flow Per Share TTM	2.28	2.24	2.25	2.22	2.29	1.90	1.78	1.82	1.97	1.95	2.08	1.75
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	24.11%	23.63%	22.94%	22.34%	21.99%	21.71%	12.61%	12.82%	12.59%	12.52%	14.10%	13.71%
Operating Profit Margin TTM	7.46%	6.62%	6.77%	6.18%	6.03%	5.78%	3.34%	3.65%	3.41%	3.26%	3.22%	2.93%
Net Profit Margin TTM	5.23%	4.54%	4.46%	4.28%	4.33%	4.66%	2.93%	3.22%	3.18%	3.25%	3.24%	3.22%
Growth Metrics
Net Revenue Growth (1Y)	6.59%	10.40%	-35.18%	-36.36%	-37.04%	-38.80%	21.91%	27.55%	33.29%	40.29%	129.32%	147.96%
Net Income Growth (1Y)	28.95%	7.70%	-1.23%	-15.34%	-14.30%	-12.41%	10.20%	27.31%	42.24%	104.35%	23.66%	8.05%
EPS Growth (1Y)	36.24%	15.03%	3.42%	-7.34%	-3.29%	-9.03%	16.84%	28.50%	38.33%	98.27%	19.54%	4.89%
Valuation Metrics
P/E TTM	20.30	37.59	32.72	35.52	36.38	29.04	26.36	42.80	60.09	56.95	62.51	75.62
P/B TTM	3.13	4.26	3.31	3.66	4.09	3.74	3.47	5.89	6.44	6.38	6.30	7.94
P/S TTM	1.06	1.71	1.46	1.52	1.57	1.35	0.77	1.38	1.91	1.85	2.02	2.44
Market Cap	1.37B	2.20B	1.85B	1.89B	1.91B	1.58B	1.51B	2.69B	3.68B	3.53B	3.25B	3.73B
Enterprise Value	1.24B	2.09B	1.71B	1.75B	1.80B	1.42B	1.42B	2.59B	3.57B	3.44B	3.09B	3.56B
Calculated Values
Free Cash Flow TTM	184.42M	191.78M	193.46M	190.20M	195.78M	173.70M	160.41M	170.92M	190.34M	185.17M	198.99M	165.41M
Net Debt	-133.57M	-114.19M	-139.98M	-137.54M	-114.24M	-162.31M	-91.48M	-94.96M	-114.96M	-97.30M	-158.08M	-170.57M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-04Sale

Owner: Livingston, Mark S.

Title: CHIEF FINANCIAL OFFICER

Shares: 2,517

Price/Share: $25.50

Value: $64,183.50

Shares Owned: 74,688

Relationship: Officer

Ownership: Direct

2026-06-04Sale

Owner: Swartz, Allison

Title: EVP, GC

Shares: 599

Price/Share: $25.08

Value: $15,022.92

Shares Owned: 82,378

Relationship: Officer

Ownership: Direct

2026-06-02Sale

Owner: Livingston, Mark S.

Title: CHIEF FINANCIAL OFFICER

Shares: 279

Price/Share: $26.20

Value: $7,309.80

Shares Owned: 78,626

Relationship: Officer

Ownership: Direct

2026-06-02Sale

Owner: Clapp, Geoffrey

Title: Chief Product Officer

Shares: 1,530

Price/Share: $25.58

Value: $39,137.40

Shares Owned: 59,117

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: Scott, Cheryl

Title: -

Shares: 7,439

Price/Share: $26.39

Value: $196,315.21

Shares Owned: 19,772

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-04	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	2,517	25.50	$64,183.50	74,688	4
2026-06-04	Swartz, Allison	Officer	EVP, GC	Direct	Sale	599	25.08	$15,022.92	82,378	4
2026-06-02	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	279	26.20	$7,309.80	78,626	4
2026-06-02	Clapp, Geoffrey	Officer	Chief Product Officer	Direct	Sale	1,530	25.58	$39,137.40	59,117	4
2026-06-01	Scott, Cheryl	Director	-	Direct	Sale	7,439	26.39	$196,315.21	19,772	4
2026-05-28	Swartz, Allison	Officer	EVP, GC	Direct	Sale	2,398	25.46	$61,053.08	85,191	4
2026-05-27	Gordon, Kevin K	Director	-	Direct	Sale	5,500	24.99	$137,445.00	9,318	4
2026-05-20	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	8,275	25.50	$211,012.50	79,063	4
2026-05-19	Cummings, Melissa B	Officer	Chief Operating Officer	Direct	Sale	9,578	25.00	$239,450.00	73,371	4
2026-03-04	Swartz, Allison	Officer	EVP, GC	Direct	Sale	599	17.54	$10,506.46	88,941	4
2026-03-03	Swartz, Allison	Officer	EVP, GC	Direct	Sale	4,657	17.40	$81,031.80	89,879	4
2025-12-11	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	459	25.50	$11,704.50	46,983	4
2025-12-04	Swartz, Allison	Officer	EVP, GC	Direct	Sale	530	24.59	$13,032.70	72,719	4
2025-12-02	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	213	25.50	$5,431.50	47,921	4
2025-11-28	Swartz, Allison	Officer	EVP, GC	Direct	Sale	2,398	26.87	$64,434.26	73,657	4
2025-11-17	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	21,303	25.50	$543,226.50	48,358	4
2025-11-13	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	79,500	24.29	$1,931,055.00	680,251	4
2025-09-04	Swartz, Allison	Officer	EVP, GC	Direct	Sale	599	23.53	$14,094.47	77,407	4
2025-08-28	Swartz, Allison	Officer	EVP, GC	Direct	Sale	2,398	22.96	$55,058.08	79,697	4
2025-08-11	Gordon, Kevin K	Director	-	Indirect	Sale	2,500	22.04	$55,100.00	12,501	4
2025-06-11	Scott, Cheryl	Director	-	Direct	Sale	2,675	22.07	$59,037.25	14,112	4
2024-12-26	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Purchase	150,000	14.68	$2,202,000.00	228,269	4
2024-12-23	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	209,500	14.48	$3,033,560.00	441,463	4
2024-11-23	Payson, Norman	Director	-	Indirect	Sale	200	56.29	$11,258.00	580,656	4
2024-07-16	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	9,030	30.00	$270,900.00	362,583	4
2024-06-28	Scott, Cheryl	Director	-	Direct	Sale	1,462	28.39	$41,506.18	10,098	4
2024-05-01	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	4,515	31.95	$144,254.25	380,038	4
2024-04-01	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	6,395	37.60	$240,452.00	384,553	4
2024-04-01	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	1,000	37.52	$37,520.00	83,631	4
2024-04-01	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	11,165	37.61	$419,915.65	50,119	4
2024-03-27	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	71,272	37.80	$2,694,081.60	86,312	4
2024-03-26	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	305	37.50	$11,437.50	86,312	4
2024-03-21	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	5,826	37.74	$219,873.24	86,312	4
2024-03-01	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	11,009	36.63	$403,259.67	141,738	4
2024-03-01	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	12,610	36.58	$461,273.80	38,254	4
2024-02-06	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	2,260	40.00	$90,400.00	158,532	4
2024-02-05	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	20,000	38.61	$772,200.00	86,312	4
2024-02-02	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	30,000	38.95	$1,168,500.00	86,312	4
2024-02-01	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	12,651	37.86	$478,966.86	43,871	4
2024-02-01	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	6,395	37.89	$242,306.55	160,792	4
2024-01-08	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	66,002	37.88	$2,500,155.76	86,312	4
2024-01-02	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	6,395	36.81	$235,399.95	167,187	4
2024-01-02	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	13,998	37.58	$526,044.84	88,439	4
2024-01-02	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	12,368	36.67	$453,534.56	46,871	4
2023-12-27	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	76,031	37.66	$2,863,327.46	88,439	4
2023-12-22	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	80,000	38.11	$3,048,800.00	88,439	4
2023-12-14	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	1,063	37.53	$39,894.39	88,439	4
2023-12-11	Gordon, Kevin K	Director	-	Direct	Sale	2,500	35.93	$89,825.00	9,854	4
2023-12-01	Livingston, Mark S.	Officer	CHIEF FINANCIAL OFFICER	Direct	Sale	25,087	34.62	$868,511.94	49,983	4
2023-12-01	Sturmer, Michael E	Officer	PRESIDENT	Direct	Sale	12,696	34.13	$433,314.48	173,806	4
2023-08-07	Bonderman, David, Tpg Gp …	Other	-	Indirect	Sale	2,900,000	41.08	$119,132,000.00	6,350,000	4
2023-07-14	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	17,990	38.95	$700,710.50	207,947	4
2023-07-13	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	67,457	38.95	$2,627,450.15	70,806	4
2023-07-13	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	32,000	38.94	$1,246,080.00	207,947	4
2023-07-03	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	18,856	38.76	$730,858.56	73,487	4
2023-07-03	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	6,439	38.78	$249,704.42	215,924	4
2023-06-27	Scott, Cheryl	Director	-	Direct	Sale	1,170	37.27	$43,605.90	9,744	4
2023-06-07	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	16,000	41.10	$657,600.00	215,924	4
2023-06-06	Anevski, Peter	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Sale	16,000	40.98	$655,680.00	215,924	4
2023-06-05	Schlanger, David J	Director,Officer	Executive Chairman	Direct	Sale	41,666	39.72	$1,654,973.52	73,487	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

84.16%

Inst. Shares: 68,102,599

Shares Outstanding: 80,920,993

2025-12-31

88.95%

Inst. Shares: 76,188,712

Shares Outstanding: 85,651,721

2025-09-30

90.99%

Inst. Shares: 78,264,828

Shares Outstanding: 86,017,342

2025-06-30

85.63%

Inst. Shares: 73,443,476

Shares Outstanding: 85,766,254

2025-03-31

80.82%

Inst. Shares: 69,099,244

Shares Outstanding: 85,499,153

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	68,102,599	80,920,993	84.16%
2025-12-31	76,188,712	85,651,721	88.95%
2025-09-30	78,264,828	86,017,342	90.99%
2025-06-30	73,443,476	85,766,254	85.63%
2025-03-31	69,099,244	85,499,153	80.82%
2024-12-31	77,026,176	91,481,995	84.20%
2024-09-30	76,067,320	90,067,675	84.46%
2024-06-30	82,974,440	93,868,409	88.39%
2024-03-31	87,259,176	96,484,657	90.44%
2023-12-31	82,195,535	95,021,175	86.50%
2023-09-30	85,915,562	95,502,250	89.96%
2023-06-30	84,800,809	94,738,651	89.51%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Progyny, Inc. (PGNY) — SEC Financial Statements & Analysis

Progyny, Inc. (PGNY) is a services-misc health & allied services, nec company, incorporated in DE. Progyny, Inc. trades on Nasdaq as: PGNY. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Progyny, Inc. reported a 6.59% year-over-year revenue growth, a Gross Profit Margin of 24.11% (TTM), a Debt-to-Equity ratio of 0.59x, a Price-to-Sales (P/S) ratio of 1.06x (TTM), a Price-to-Book (P/B) ratio of 3.13 (TTM), at a market cap of $1.37B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 6.59%
Gross Profit Margin TTM: 24.11%
Debt To Equity: 0.59x
P/S TTM: 1.06x
P/B TTM: 3.13
Market Cap: $1.37B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Progyny, Inc. in?

Progyny, Inc. (PGNY) operates in the Services-Misc Health & Allied Services, NEC industry.

What is PGNY's market cap?

Progyny, Inc. (PGNY) has a market capitalization of $1.37B as of 2026-03-31.

What is PGNY's P/E ratio?

Progyny, Inc. (PGNY)'s trailing twelve month P/E ratio is 20.30x as of 2026-03-31.

What exchange does PGNY trade on?

Progyny, Inc. (PGNY) trades on the Nasdaq.

Where is Progyny, Inc. incorporated?

Progyny, Inc. is incorporated in DE.

Progyny, Inc. (PGNY) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.